$19.45

-2.05 (-9.53%)

Weekly Expected Move ±10.5%

$15 $17 $19 $22 $24

OTC · Healthcare · Medical - Distribution · Tech Score Sell · Power 39 · $997.0M mcap · 49M float · 0.0001% daily turnover · Short 73% of daily vol

Revenue

$13.2B -8.3% ▼

5Y CAGR: +17.6%

Gross Profit

$1.8B -1.2% ▼

5Y CAGR: +12.3%

Operating Income

$456M -13.6% ▼

5Y CAGR: +10.0%

Net Income

$232M -21.9% ▼

5Y CAGR: +5.9%

EPS (Diluted)

$4.70 -23.9% ▼

5Y CAGR: +1.8%

EBITDA

$580M -10.8% ▼

5Y CAGR: +21.1%

View Full Income Statement

Line Item	FY2020	FY2021	FY2022	FY2023	FY2024
Revenue	$9.9B	$11.9B	$13.3B	$14.4B	$13.2B
YoY Growth	+68.3%	+20.4%	+11.9%	+8.2%	-8.3%
Cost of Revenue	$8.8B	$10.5B	$11.6B	$12.6B	$11.4B
Gross Profit	$1.1B	$1.4B	$1.7B	$1.8B	$1.8B
Gross Margin	10.8%	11.6%	12.8%	12.4%	13.3%
R&D Expenses	$0	$0	$0	$0	$0
SG&A Expenses	$382M	$285M	$307M	$619M	$633M
Operating Expenses	$749M	$985M	$1.2B	$1.3B	$1.3B
Operating Income	$318M	$251M	$499M	$527M	$456M
Operating Margin	3.2%	2.1%	3.7%	3.7%	3.4%
Interest Expense	$22M	$25M	$74M	$91M	$96M
Income Before Tax	$283M	$327M	$406M	$419M	$325M
Tax Expense	$85M	$103M	$120M	$120M	$93M
Net Income	$199M	$225M	$276M	$297M	$232M
Net Margin	2.0%	1.9%	2.1%	2.1%	1.8%
EPS (Diluted)	$4.86	$5.08	$5.78	$6.18	$4.70
EBITDA	$383M	$444M	$616M	$650M	$580M
Shares Outstanding	41M	44M	48M	48M	49M

Line Item	FY2021 Q2	FY2021 Q4	FY2022 Q2	FY2022 Q4	FY2023 Q2	FY2023 Q4	FY2024 Q2	FY2024 Q4
Revenue	$3.8B	$3.9B	$4.1B	$4.1B	$4.3B	$4.3B	$4.0B	$4.0B
Cost of Revenue	$3.6B	$3.6B	$3.8B	$3.8B	$4.0B	$4.0B	$3.7B	$3.7B
Gross Profit	$252M	$292M	$307M	$309M	$311M	$316M	$300M	$296M
Gross Margin	6.5%	7.4%	7.5%	7.5%	7.2%	7.3%	7.6%	7.4%
R&D Expenses	$0	$0	$0	$0	$0	$0	$0	$0
SG&A Expenses	$127M	$157M	$158M	$149M	$152M	$152M	$157M	$160M
Operating Expenses	$131M	$162M	$159M	$157M	$154M	$157M	$158M	$164M
Operating Income	$121M	$130M	$148M	$152M	$157M	$160M	$142M	$132M
Operating Margin	3.1%	3.3%	3.6%	3.7%	3.7%	3.7%	3.6%	3.3%
Interest Expense	$11M	$12M	$25M	$28M	$32M	$34M	$36M	$37M
Income Before Tax	$105M	$102M	$125M	$117M	$121M	$122M	$103M	$93M
Tax Expense	$33M	$34M	$37M	$37M	$36M	$36M	$29M	$27M
Net Income	$75M	$72M	$89M	$82M	$89M	$89M	$73M	$66M
Net Margin	1.9%	1.8%	2.2%	2.0%	2.1%	2.0%	1.8%	1.7%
EPS (Diluted)	$1.80	$1.52	$1.86	$1.72	$1.86	$1.86	$1.50	$1.32
EBITDA	$144M	$145M	$193M	$187M	$196M	$197M	$180M	$175M
Shares Outstanding	41M	47M	47M	48M	48M	48M	49M	50M

EBOSY OTC